No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Minerva Saudi Powers Vision 2030 With Red Sea Logistics Investment
Minerva Neurosciences | 10-K/A: Annual report (Amendment)
12 Health Care Stocks Moving In Monday's After-Market Session
Minerva Neurosciences: Cash, Cash Equivalents and Restricted Cash at Dec 31 Were $21.5M >NERV
Press Release: Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Minerva Neurosciences 4Q Loss/Shr 56c >NERV